WHO WE ARE
FCF is a specialized Investment Bank and Financing Specialist, advising public and private mid-market companies in the German speaking regions:
- Mid-market clients with an annual turnover of EUR 100 million to EUR 1 billion primarily within the traditional German industries such as Automotive, Communications, Industrials, Machinery, Pharma & Healthcare, Renewables, Software & IT, Transportation & Logistics
- High-growth and venture-type companies in R&D- and patent-driven segments such as Life Sciences and Real-Technology
FCF arranges, structures, and places equity and debt capital and supports its clients’ growth, IPO/Pre-IPO, acquisition and standard balance sheet (re-)financing strategies.
WHO WE SERVE
WHAT WE DO
(click below for details)
- with the best conditions,
- with the highest flexibility,
- in the shortest period of time,
- with the highest closing probability,
- with long-lasting financial partners that suit the company’s objectives.
- Deep knowledge and understanding of all relevant financial instruments across the debt and equity space:
- 360-degree perspective, offering maximum independence and freedom
- Complete financial markets insight with direct access to all relevant institutional investors and financiers
- Strategic approach in searching and selecting suitable investors
- Development, structuring and placing of comprehensive financial solutions combined with targeted financing measures
- The most creative team, specialized in the financing of SMEs
- Proactive, independent process management for strengthened negotiation leverage
- Focus on SMEs in the DACH region
- Quintessential medium-sized companies (“Mittelstand”) with revenues between EUR 100m and EUR 1,000m
- Fast growing companies operating established and proven business models
- Ultra-high growth, innovative companies with revolutionary technologies / products, for instance in life science and high-tech
- Access to & established network with the largest families, family offices and Ultra High Net Worth investors
- Discrete, bilateral discussions behind closed doors
- Direct investments with entrepreneurial and co-operative approach
- Long-term investment horizons all the way to evergreen funding
- Direct access to key executives at all top-tier and mid-sized investment banks
- to the market-leading, market-influencing sector experts
- to investment banking, capital markets and research departments
- Top-tier institutional US investors with focus on and interest in DACH enterprises
- Contact to selected “high profile” Ultra High Net Worth investors and family offices
- Exclusive dialog with the entrepreneurs / owners
- 100% focus on the requirements and interests
- Confidant and creative motivator in the decision-making process
- Maximization of alternative courses of action
RECENT TRANSACTIONS
Synapticon GmbH
December 2018
> € 10 million
Investment in
December 2018
> € 10 million
GSE Group Acquisition by Finexx
December 2018
[amount confidential]
GSE Group Acquisition by Finexx
November 2018
[amount confidential]
RECENT NEWS
FCF Fox Corporate Finance strengthens its Life Science Advisory Board with the appointment of Dr. Alexandra Goll and Prof. Dr. Horst Domdey
Munich, Germany, 21. March 2019 (fcf) – FCF Fox Corporate Finance strengthens its Life Science Advisory Board with the appointment of Dr. Alexandra Goll and Prof. Dr. Horst Domdey FCF Fox Corporate Finance (“FCF”) is
FCF Fox Corporate Finance advises Synapticon GmbH on its equity increase
Munich, January 2019 (fcf) – FCF Fox Corporate Finance advises Synapticon GmbH on its equity increase FCF Fox Corporate Finance acted as advisor to the management of Synapticon GmbH, a developer and manufacturer of specialized
FCF at the traditional BioM Dinner
The BioM – Biotechnologiecluster Management for Munich & Bayern organized the traditional BioM Dinner on the 4th of December in the Lenbach Palais with guests from the German life science sector. (to news) Arno Fuchs spoke